
$1.7 Million Awarded in 2021 for Research Grants
Glaucoma Research Foundation announces a total of $1.7 million in annual research grants to support 13 investigators at prestigious colleges and universities across the United States.
Glaucoma Research Foundation announces a total of $1.7 million in annual research grants to support 13 investigators at prestigious colleges and universities across the United States.
The Shaffer Prize, presented annually by Glaucoma Research Foundation, recognizes a researcher whose project best exemplifies the pursuit of innovative ideas in the quest to cure glaucoma.
Ophthalmology industry leader Ramin Valian, Vice President, Glaucoma and Reimbursement US at Allergan, was honored at the Glaucoma 360 Virtual Annual Gala on January 29, 2021.
Findings from survey of more than 1,000 Americans suggest one-third lacked confidence that their disease was well-managed during early phase of lockdowns. Appointment delays and cancellations were the greatest cause of concern.
During the COVID-19 pandemic, statewide shutdowns impacted regularly scheduled eye exams and access to prescription medications, prompting broader concerns about health and safety.
Terri Pickering, MD is a glaucoma specialist at Glaucoma Center of San Francisco, a clinical instructor at California Pacific Medical Center and a researcher with the Glaucoma Research and Education Group.
Glaucoma Research Foundation announced a total of $1.2 million in annual research grants to support 12 investigators at prestigious colleges and universities across the United States.
Allergan has announced the approval of DURYSTA™ (bimatoprost implant), the first biodegradable sustained-release implant for the treatment of open-angle glaucoma
The Gleams Newsletter includes interviews, personal stories, and current information about glaucoma, new treatments, updates on research findings, and more. You can subscribe to the printed version of Gleams or the electronic version — both are free.
The Gleams Newsletter includes interviews, personal stories, and current information about glaucoma, new treatments, updates on research findings, and more. You can subscribe to the printed version of Gleams or the electronic version — both are free.
FOR EYECARE PROFESSIONALS
FOR EYECARE PROFESSIONALS
Glaucoma Research Foundation • 251 Post Street, Suite 600 • San Francisco, CA 94108 • 415-986-3162
Send us an email
We are a 501c3 tax-exempt national nonprofit. Our tax ID number is 94-2495035. Our EIN number is 94-2495035.
Copyright 2022 all rights reserved.
Print Subscription
(The printed edition of the Gleams newsletter is only available if you live in the United States or Canada)
You can unsubscribe at any time. GRF will not share your personal information with any other organizations. Please see our Privacy Policy for further information.
E-mail Subscription
You can unsubscribe at any time. GRF will not share your personal information with any other organizations. Please see our Privacy Policy for further information.